Building on the company's validated enzymatic process for green ibuprofen synthesis, the expanded program leverages Quantumzyme's enzyme families, machine learning predictive models, and in silico ...
At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, ...
Cipla also upgraded to smart systems across all sites with Datatech Architecture, enabling seamless access to critical ...
Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...
Manufacturing organizations are confronted with clear choices: proactively transform operations or accept competitive decline ...
Greg Miraglia and Jeff Nardinelli of Quinn Emanuel Urquhart & Sullivan LLP discuss the potential and successes of low-orbit ...
Crystallization is a vital step in the development and production of small molecule active pharmaceutical ingredients (APIs), playing a pivotal role in defining the purity, stability and ...
ALBANY, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million ...
Abu Dhabi, UAE – Al Gharbia Pipe Company (AGPC), an Abu Dhabi-based producer of longitudinally submerged arc welded (LSAW) ...
Quantumzyme Corp. (OTC: QTZM), a leader in computational enzyme engineering and green chemistry innovation, proudly announces the publication of its pioneering research on sustainable ibuprofen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback